Bachem at leading peptide and oligo events

Bubendorf, Switzerland: –Specialist CDMO Bachem AG will be represented at three key events in the world of peptides and oligonucleotides occurring during the second half of September 2024, in Europe, North America, and online.

Bachem’s presence at the Boulder Peptide Symposium in Colorado, the Nordic Life Science Days meeting in Sweden and the online Oligo Chemistry & Therapeutics Online Symposium highlights its leading role as a leading-edge manufacturer of peptides and oligomers.

Bachem at Boulder Peptide Symposium 2024

Bachem is a Platinum Sponsor of the annual Boulder Peptide Symposium in the USA which provides a unique platform for key players in the biotech and pharmaceutical industry to share knowledge in an intimate setting.

Bachem’s team in Boulder, Colorado, will be headed by its Vice President Peptide Manufacturing Upstream Dr. Stefan Eissler and Vice President & Head, Global Business Development Chris McGee, and Head of Business Development, Naoki Yamamoto. They will be supported by Business Development Managers Keith Porter, Frederica Decò, Noah Duffy, and Dawson Chen, Business Development Sales Manager for Asia.

On Day 3, Dr. Eissler will deliver a presentation on ‘Synthetic Peptide Manufacturing: Options for the Upstream Process’, followed by the Bachem sponsored panel discussion on ‘Preclinical Development: The “Black Box” between Med Chem and Clinical’, featuring panelists Dave Garman of Boulder Peptide SAB, Peter Korytko from Preclinical GPS, and Jennifer Martin of Eli Lilly. The discussion will cover topics such as a toxicity program for peptides, how to pick clinical dose, and preclinical to clinical translation.

Bachem at Nordic Life Science Days 2024

Simultaneously in Europe, Bachem will also be present at the important Scandinavian meeting, Nordic Life Science Days from September 17 to 19 in Malmö, Sweden.

Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. Since its inception in 2013, the event has nurtured a community of people from the world of life sciences and created a uniquely informal hybrid scientific and business event.

The Bachem team in Malmö will include Business Development Manager for Oligonucleotides Mathias Beysard and Senior Business Development Manager Bernd Raschack

Bachem at Oligo Chemistry & Therapeutics Online Symposium 2024

Just over a week after returning from Sweden, Mathias Beysard, will also represent Bachem at a global online event, the Oligo Chemistry & Therapeutics Online Symposium hosted by Oxford Global on September 27.

This premier virtual meeting for professionals in oligo chemistry and therapeutics will provide a chance to hear from leading experts in areas such as peptide-oligo conjugation, modification chemistry, and advanced synthesis tools, and explore the commercialization of oligonucleotide therapeutics through clinical case studies.

About Boulder Peptide Symposium 2024

The Boulder Peptide Foundation (BPF), headquartered in Boulder, Colorado, is a non-profit 501(3) corporation focused on public peptide therapeutics. The Society organizes the Annual Boulder Peptide Symposium as a key vehicle for driving the science and technology in this important field.

Founded in 2012, the BPS meeting is branded as the only conference solely focused on the pharmaceutical development of peptide therapeutics.

BPS 2024 is a four-day event opening September 16 at the St. Julien Hotel in Boulder, Colorado. One of the highlights of the 2024 meeting will be the Meienhofer Award Lecture, presented by Prof. Fernando Albericio, of the Universities of Barcelona and KwaZulu-Natal, explaining ‘Solid-Phase Peptide Synthesis as a Puzzle of Resins, Protecting Groups, Coupling Reagents in a Proper Solvent’.

The event is organised by the Boulder Peptide Foundation with further information at: https://www.boulderpeptide.org/

About Nordic Life Science Days 2024

Nordic Life Science Days (NLSDays) is Scandinavia’s largest partnering conference for the global Life Science industries for leading decision makers from the whole Life Sciences sector, including not only biotech, pharma and Medtech but also finance, research, policy, and regulatory authorities. The event has grown steadily over the past three years, from 650 participants in 2013 to some 1,600 at last year’s conference in Copenhagen.

The 11^th NLSDays meeting is a three-day event opening September 17, at the Malmömässan center in Malmö, Sweden.

Along with networking sessions powered by the BIO One-On-One Partnering™ system, the conference will also feature fireside chats, super sessions focusing on success stories from the Nordic life science sector, company presentations forum, an Innovative Posters competition, and the Nordic Stars pitch competition for up-and-coming innovators, competing for attractive prize packages.

The event is organized by Sweden Bio and BioNordic, with more information at: http://www.nlsdays.com

About Oligo Chemistry & Therapeutics Online Symposium 2024

Therapeutics Symposium is a premier event for professionals in oligo chemistry and therapeutics who wish to engage with global innovators, learn about peptide-oligo conjugation, modification chemistry, and advanced synthesis tools, and explore the commercialization of oligonucleotide therapeutics through clinical case studies.

The Oligo Chemistry and Therapeutics Online Symposium is a half-day event, commencing 1300 hrs. on September 27, 2024. Key topics covered will include overcoming therapeutic challenges, optimizing targeted delivery, and advanced analytical methods in liquid chromatography and mass spectrometry.

The session concludes with a summary of the ‘Harnessing Oligo Chemistry & Therapeutics Development with Best Practice Approaches’ report that is provided to attendees.

The event is organized by Oxford Global Marketing, with further information and registration link available at https://oxfordglobal.com/biologics/events/oligo-chemistry-therapeutics-online-symposium

About Bachem

Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.

Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.

For further information, see www.bachem.com

Resources

Click on Bachem at Boulder Peptides Symposium 2024 for further information.
Click on Bachem at  Nordic Life Science Days 2024 for further information.
Click on Bachem at Online Oligo Therapeutics Symposium 2024  for further information.
Click on Bachems News to see latest News & Events.